IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Influx Healthtech IPO is a Book Building IPO listing on NSE EMERGE exchange, with an ipo size of ₹ 58.57 Cr. The company is based in Mumbai and caters to Healthcare sector. Rarever Financial Advisors is the merchant banker of Influx Healthtech IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 4th February 2025.
Influx Healthtech IPO open date is 18th June 2025 and close date is 20th June 2025. IPO Allotment Date is 23rd June 2025 and Listing date is 25th June 2025.
IPO
Size:
₹ 58.57 Cr.
Avg IPO Size (Sector Based)
: ₹
25.58 cr.
Sector: Healthcare
SME
IPO so far:
43
Merchant Banker:
Rarever Financial
SME
IPO by BRLM so far:
0
City:
Mumbai
SME
IPO so far:
56
Revenue (annualised):
₹
104.85
cr. 
PE
Ratio:
16.63x
Average Sector PE Ratio: 19.30x
Influx Healthtech IPO size is ₹ 58.57 Cr. with IPO price of ₹ 96.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Rarever Financial Advisors Private Limited is the book-running lead manager of the Influx Healthtech IPO. Maashitla Securities Private Limited is the Registrar and Market Maker is R.K. Stock Holding Private Limited for Influx Healthtech IPO.
Influx Healthtech IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Influx Healthtech IPO, based in Mumbai, operates in the Healthcare sector with a focus on healthcare product-focused company. The company is launching its SME Upcoming IPO on the NSE EMERGE exchange, using the Book Building Issue method. Influx Healthtech IPO size is ₹ 58.57 Cr. with fresh issue size of ₹ 10.56 Cr. and Offer for sale being ₹ 48.01Cr.
The IPO allotment date for Influx Healthtech IPO is expected to be 23rd June 2025, after the finalization of basis of allotment. Investors can check Influx Healthtech IPO allotment status on the registrars website, Maashitla Securities Private Limited . Influx Healthtech IPO refund dates are 24th June 2025.
Influx Healthtech IPO is expected to be listed on 25th June 2025.
The upper price band for the Influx Healthtech IPO is set at ₹ 96.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Influx Healthtech IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Influx Healthtech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 20th June 2025. After submission, funds are blocked until the basis of allotment of Influx Healthtech IPO is finalised.
The merchant banker for Influx Healthtech IPO is Rarever Financial Advisors Private Limited . Rarever Financial Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Influx Healthtech IPO RHP for further details.
The registrar for Influx Healthtech IPO is Maashitla Securities Private Limited . Investors can go to Maashitla Securities Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Influx Healthtech IPO through their official website or helpline.
Influx Healthtech IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 58.57 Cr.
Avg IPO Size (Sector Based)
:
₹ 25.58 Cr.
Sector: Healthcare
SME
IPO so far:
43
Merchant Banker:
Rarever Financial
SME
IPO by BRLM so far:
0
City:
Mumbai
SME
IPO so far:
56
Revenue (annualised):
₹ 104.85 cr.
PE
Ratio:
16.63x
Average Sector PE Ratio: 19.30x
Influx Healthtech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Influx Healthtech Financial Review Page
Merchant Banker(s) of Influx Healthtech IPO: Rarever Financial Advisors Private Limited
Influx Healthtech IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Influx Healthtech IPO listed at a listing price of against the offer price of 96.00.
The current market price of Influx Healthtech is .
Why Us?
